Agid Y - Search Results

1

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y. Anglade P, et al. Among authors: agid y. Histol Histopathol. 1997 Jan;12(1):25-31. Histol Histopathol. 1997. PMID: 9046040

2

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y. Kastner A, et al. Among authors: agid y. J Neurochem. 1992 Sep;59(3):1080-9. doi: 10.1111/j.1471-4159.1992.tb08350.x. J Neurochem. 1992. PMID: 1494900

3

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.

Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y. Javoy-Agid F, et al. Among authors: agid y. Neuroscience. 1990;38(1):245-53. doi: 10.1016/0306-4522(90)90389-l. Neuroscience. 1990. PMID: 1979431

4

Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.

Thibaut F, Hirsch EC, Raisman R, Javoy-Agid F, Agid Y. Thibaut F, et al. Among authors: agid y. Neuroscience. 1990;37(2):387-98. doi: 10.1016/0306-4522(90)90409-w. Neuroscience. 1990. PMID: 1983469

5

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y. Hirsch EC, et al. Among authors: agid y. J Neurochem. 1991 Feb;56(2):446-51. doi: 10.1111/j.1471-4159.1991.tb08170.x. J Neurochem. 1991. PMID: 1988548

6

Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?

Hirsch EC, Duyckaerts C, Javoy-Agid F, Hauw JJ, Agid Y. Hirsch EC, et al. Among authors: agid y. Ann Neurol. 1990 Jun;27(6):676-82. doi: 10.1002/ana.410270615. Ann Neurol. 1990. PMID: 2360804

7

Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.

Hirsch EC, Graybiel AM, Agid Y. Hirsch EC, et al. Among authors: agid y. Acta Neurol Scand Suppl. 1989;126:19-22. doi: 10.1111/j.1600-0404.1989.tb01778.x. Acta Neurol Scand Suppl. 1989. PMID: 2575832

8

Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?

Mouatt-Prigent A, Agid Y, Hirsch EC. Mouatt-Prigent A, et al. Among authors: agid y. Brain Res. 1994 Dec 30;668(1-2):62-70. doi: 10.1016/0006-8993(94)90511-8. Brain Res. 1994. PMID: 7704619

9

Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.

Anglade P, Tsuji S, Javoy-Agid F, Agid Y, Hirsch EC. Anglade P, et al. Among authors: agid y. Ann Neurol. 1995 Feb;37(2):265-72. doi: 10.1002/ana.410370219. Ann Neurol. 1995. PMID: 7847868

10

Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum.

Herrero MT, Hirsch EC, Javoy-Agid F, Obeso JA, Agid Y. Herrero MT, et al. Among authors: agid y. Brain Res. 1993 Oct 8;624(1-2):281-5. doi: 10.1016/0006-8993(93)90088-5. Brain Res. 1993. PMID: 7902770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters